US Patent Issued to Xyra on Feb. 17 for "Methods for reducing the risk of heart failure or strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations" (California Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,706, issued on Feb. 17, was assigned to Xyra LLC (Los Altos, Calif.).

"Methods for reducing the risk of heart failure or strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations" was invented by Pascal Druzgala (Santa Rosa, Calif.) and Peter Gerard Milner (Mountain View, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods to treat patients with AFib by monitoring their heart rhythm to determine the presence and/or the number of episodes of long duration AFib, and optionally the extent of AFib burden. Patients who meet threshold requirements are qualified for the treatment of AFib with a dosage of b...